Anticancer agent 109
Anticancer agent 109 (compound 6-15) is an inhibitor of the Gas6-Axl axis with anti-cancer activity. Anticancer agent 109 inhibits the expression of Gas6 and Axl, and the expression p-PI3K and p-AKT in cancer cells, leads to G1 phase arrest and promotes cancer cells apoptosis, and inhibits tumor growth significantly in nude mouse tumor bearing models.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2097497-16-8
- 分子式: C19H15N3O2
- 分子量:317.34
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
Axl |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
4.2 μM
Compound: 6-15
|
Cytotoxicity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36921529] |
| CHO-K1 | IC50 |
54.5 μM
Compound: 6-15
|
Cytotoxicity against CHO-K1 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against CHO-K1 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36921529] |
| DU-145 | IC50 |
1.1 μM
Compound: 6-15
|
Cytotoxicity against human DU-145 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human DU-145 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36921529] |
| HEK293 | IC50 |
26.2 μM
Compound: 6-15
|
Cytotoxicity against HEK293 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against HEK293 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36921529] |
| HT-29 | IC50 |
4.6 μM
Compound: 6-15
|
Cytotoxicity against human HT-29 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human HT-29 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36921529] |
| MCF7 | IC50 |
2 μM
Compound: 6-15
|
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36921529] |
| MDA-MB-231 | IC50 |
2.8 μM
Compound: 6-15
|
Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36921529] |
| PANC-1 | IC50 |
4 μM
Compound: 6-15
|
Cytotoxicity against human PANC-1 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human PANC-1 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36921529] |
| U-937 | IC50 |
6.7 μM
Compound: 6-15
|
Cytotoxicity against human U-937 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human U-937 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 36921529] |
Anticancer agent 109 (10 μM,48 h) inhibits of Gas6 and Axl in A549, inhibits of Gas6-Axl axis related proteins, increases the sub-G1 fraction and promotes of late stage apoptosis without altering DNA synthesis in PANC-1[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7; PANC-1; MDA-MB-231 ; HT-29 ; DU145 ; U937 ; A549 ; PANC-1
-
Concentration:30 μM
-
Incubation Time:48 h
-
Result:Inhibited the growth of cancer cells, and was up to 20-fold safer against normal cells and up to 5.4-fold more active than Sunitinib against the cancer cells.
Inhibited growth with IC50s of 2.0 μM (MCF-7); 2.8 μM (MDA-MB-231); 4.6 μM (HT-29); 1.1 μM (DU145); 6.7 μM (U937); 4.2 μM (A549); 4.0 μM (PANC-1).
-
Cell Line:PANC-1
-
Concentration:1 μM , 5 μM , 10 μM
-
Incubation Time:48 h
-
Result:Increased the sub-G1 fraction and induced late apoptosis.
-
Cell Line:A549; PANC-1
-
Concentration:10 μM
-
Incubation Time:48 h
-
Result:Inhibited Gas6 and Axl in A549 and PANC-1 cell, increased the expression ratio of Bax/Bcl-2 and inhibited p-PI3K and p-AKT in PANC-1 cell.
-
Cell Line:PANC-1
-
Concentration:3 μM ;5 μM 10 μM
-
Incubation Time:48 h
-
Result:Inhibited Gas6 and Axl.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:A549 or PANC-1 xenografted in BALB/c-nu mice[1].
-
Dosage:1 mg/kg; 3 mg/kg
-
Administration:Intraperitoneal injection (i.p.) 6 times a week
-
Result:Promoted tumor regression to around a quarter with 1 mg/kg, smaller but not eliminated with 3 mg/kg in A549 models.
Promoted tumor regression to around a quarter with 3 mg/kg in PANC-1 models.
化学情報
-
CAS 番号 2097497-16-8
-
分子量 317.34
-
分子式 C19H15N3O2
-
SMILES
O=C(/C(C1=C2C)=C\C3=NC4=C(C=CC=C4)C=C3)NC1=NC(C)=C2O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)